2014, Número 3
<< Anterior Siguiente >>
Ann Hepatol 2014; 13 (3)
An update on management of Budd-Chiari syndrome
Mancuso A
Idioma: Ingles.
Referencias bibliográficas: 29
Paginas: 323-326
Archivo PDF: 66.97 Kb.
RESUMEN
Sin resumen.
REFERENCIAS (EN ESTE ARTÍCULO)
DeLeve LD, Valla DC, Garcia-Tsao G. Vascular disorders of the liver. Hepatology 2009; 49: 1729-64.
Plessier A, Sibert A, Consigny Y, Hakime A, Zappa M, Denninger MH, Condat B, et al. Aiming at minimal invasiveness as a therapeutic strategy for Budd-Chiari syndrome. Hepatology 2006; 44: 1308-16.
Mancuso A. Budd-Chiari syndrome management: lights and shadows. World J Hepatol 2011; 3: 262-4.
Bilbao JI, Pueyo JC, Longo JM, Arias M, Herrero JI, Benito A, Barettino MD, et al. Interventional therapeutic techniques in Budd-Chiari syndrome. Cardiovasc Intervent Radiol 1997; 20: 112-19.
Fisher NC, McCafferty I, Dolapci M, Wali M, Buckels JA, Olliff SP, Elias E. Managing Budd-Chiari syndrome: a retros-pective review of percutaneous hepatic vein angioplasty and surgical shunting. Gut 1999; 44: 568-74.
Eapen CE, Velissaris D, Heydtmann M, Gunson B, Olliff S, Elias E. Favourable medium term outcome following hepatic vein recanalisation and/or transjugular intrahepatic portosystemic shunt for Budd Chiari syndrome. Gut 2006; 55: 878-84.
Perelló A, García-Pagán JC, Gilabert R, Suárez Y, Moitinho E, Cervantes F, Reverter JC, et al. TIPS is a useful longterm derivative therapy for patients with Budd-Chiari syndrome uncontrolled by medical therapy. Hepatology 2002; 35: 132-9.
Mancuso A, Fung K, Mela M, Tibballs J, Watkinson A, Burroughs AK, Patch D. TIPS for acute and chronic Budd- Chiari syndrome: a single-centre experience. J Hepatol 2003; 38: 751-4.
Rössle M, Olschewski M, Siegerstetter V, Berger E, Kurz K, Grandt D. The Budd-Chiari syndrome: outcome after treatment with the transjugular intrahepatic portosystemic shunt. Surgery 2004; 135: 394-403.
Mancuso A, Watkinson A, Tibballs J, Patch D, Burroughs AK. Budd-Chiari syndrome with portal, splenic, and superior mesenteric vein thrombosis treated with TIPS: who dares wins. Gut 2003; 52: 438.
Darwish MS, Valla DC, De Groen PC, Zeitoun G, Haagsma EB, Kuipers EJ, Janssen HL. Pathogenesis and treatment of Budd-Chiari syndrome combined with portal vein thrombosis. Am J Gastroenterol 2006; 101: 83-90.
Garcia-Pagán JC, Heydtmann M, Raffa S, Plessier A, Murad S, Fabris F, Vizzini G, et al. TIPS for Budd-Chiari syndrome: long-term results and prognostics factors in 124 patients. Gastroenterology 2008; 135: 808-15.
Ringe B, Lang H, Oldhafer KJ, Gebel M, Flemming P, Georgii A, Borst HG, et al. Which is the best surgery for Budd- Chiari syndrome: venous decompression or liver transplantation? A single-center experience with 50 patients. Hepatology 1995; 21: 1337-44.
Hemming AW, Langer B, Greig P, Taylor BR, Adams R, Heathcote EJ. Treatment of Budd-Chiari syndrome with portosystemic shunt or liver transplantation. Am J Surg 1996; 171: 176-180; discussion 180-181.
Orloff MJ, Isenberg JI, Wheeler HO, Daily PO, Girard B. Budd-Chiari syndrome revisited: 38 years’ experience with surgical portal decompression. J Gastrointest Surg 2012; 16: 286-300; discussion 300.
Zhang Y, Zhao H, Yan D, Xue H, Lau WY. Superior mesenteric vein-caval-right atrium Y shunt for treatment of Budd-Chiari syndrome with obstruction to the inferior vena cava and the hepatic veins-a study of 62 patients. J Surg Res 2011; 169: e93-e99.
Srinivas BC, Dattatreya PV, Srinivasa KH, Prabhavathi CN. Inferior vena cava obstruction: long-term results of endovascular management. Indian Heart J 2012; 64: 162-9.
Mancuso A, Martinelli L, De Carlis L, Rampoldi AG, Magenta G, Cannata A, Belli LS. A caval homograft for Budd-Chiari syndrome due to inferior vena cava obstruction. World J Hepatol 2013; 27: 292-5.
Halff G, Todo S, Tzakis AG, Gordon RD, Starzl TE. Liver transplantation for the Budd-Chiari syndrome. Ann Surg 1990; 211: 43-9.
Rao AR, Chui AK, Gurkhan A, Shi LW, Al-Harbi I, Waugh R, Verran DJ, et al. Orthotopic liver transplantation for treatment of patients with Budd-Chiari syndrome: a Singecenter experience. Transplant Proc 2000; 32: 2206-207.
Ulrich F, Steinmüller T, Lang M, Settmacher U, Müller AR, Jonas S, Tullius SG, et al. Liver transplantation in patients with advanced Budd-Chiari syndrome. Transplant Proc 2002; 34: 2278.
Srinivasan P, Rela M, Prachalias A, Muiesan P, Portmann B, Mufti GJ, Pagliuca A, et al. Liver transplantation for Budd- Chiari syndrome. Transplantation 2002; 73: 973-7.
Mentha G, Giostra E, Majno PE, Bechstein WO, Neuhaus P, O’Grady J, Praseedom RK, et al. Liver transplantation for Budd-Chiari syndrome: A European study on 248 patients from 51 centres. J Hepatol 2006; 44: 520-8.
Segev DL, Nguyen GC, Locke JE, Simpkins CE, Montgomery RA, Maley WR, Thuluvath PJ. Twenty years of liver transplantation for Budd-Chiari syndrome: a national registry analysis. Liver Transpl 2007; 13: 1285-94.
Choi GS, Park JB, Jung GO, Chun JM, Kim JM, Moon JI, Kwon CH, et al. Living donor liver transplantation in Budd- Chiari syndrome: a single-center experience. Transplant Proc 2010; 42: 839-42.
Kiladjian JJ, Cervantes F, Leebeek FW, Marzac C, Cassinat B, Chevret S, Cazals-Hatem D, et al. The impact of JAK2 and MPL mutations on diagnosis and prognosis of splanchnic vein thrombosis: a report on 241 cases. Blood 2008; 111: 4922-9.
Darwish MS, Plessier A, Hernandez-Guerra M, Fabris F, Eapen CE, Bahr MJ, Trebicka J, et al. Etiology, management, and outcome of the Budd-Chiari syndrome. Ann Intern Med 2009; 151: 167-75.
Seijo S, Plessier A, Hoekstra J, Dell’Era A, Mandair D, Rifai K, Trebicka J, et al. Good long-term outcome of Budd-Chiari syndrome with a step-wise management. Hepatology 2013; 57: 1962-8.
Mancuso A. Budd-Chiari Syndrome Management: Timing of Treatment Is an Open Issue. Hepatology (IN PRESS).